40 results
Page 2 of 2
8-K
EX-10.2
s7nymkpo 95kr
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
8-K
EX-99.2
4hvachu jjzyfhqak8e
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
8-K
EX-10.1
fajb9fv7ls
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
S-3
t653ryiplfj9tn1duic
23 Oct 20
Shelf registration
4:48pm
DEF 14A
f0ovw4 8jv8ghxfpf
24 Apr 20
Definitive proxy
4:14pm
10-K
yqw9moahw
10 Mar 20
Annual report
4:20pm
8-K
EX-99.1
j51k7pk29m65h060t1
10 Mar 20
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Results
4:10pm
10-Q
3joo 7m6c5hek
12 Nov 19
Quarterly report
4:31pm
424B4
k9owi rw9xnvl24sp
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
04xb76vah01wu8k 9ta
3 Sep 19
IPO registration (amended)
6:12am
S-1
vmfsdbk rxwi
16 Aug 19
IPO registration
5:15pm
S-1
EX-4.3
82pe hgcqybhmbpyzarh
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.2
qugixxp8xq9s
16 Aug 19
IPO registration
5:15pm
DRS/A
6icuy9csv1ec2mb
2 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
nlryia686xe2 po
2 Aug 19
Draft registration statement (amended)
12:00am
DRS
nbfcb7k fg
21 Jun 19
Draft registration statement
12:00am